These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28259950)

  • 1. Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin.
    Shen F; Long D; Yu T; Chen X; Liao Y; Wu Y; Lin X
    Oncol Rep; 2017 Apr; 37(4):2481-2489. PubMed ID: 28259950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Oncoprotein 18/Stathmin Signaling by ERK Concerns the Resistance to Taxol in Nonsmall Cell Lung Cancer Cells.
    Lin X; Liao Y; Chen X; Long D; Yu T; Shen F
    Cancer Biother Radiopharm; 2016 Mar; 31(2):37-43. PubMed ID: 26881937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.
    Lin X; Yu T; Zhang L; Chen S; Chen X; Liao Y; Long D; Shen F
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):611-620. PubMed ID: 27289016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cdc2/Cdk1 inhibitor, purvalanol A, enhances the cytotoxic effects of taxol through Op18/stathmin in non-small cell lung cancer cells in vitro.
    Chen X; Liao Y; Long D; Yu T; Shen F; Lin X
    Int J Mol Med; 2017 Jul; 40(1):235-242. PubMed ID: 28534969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Op18/stathmin is involved in the resistance of taxol among different epithelial carcinoma cell lines.
    Lin X; Liao Y; Xie J; Liu S; Su L; Zou H
    Cancer Biother Radiopharm; 2014 Nov; 29(9):376-86. PubMed ID: 25379611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAi targeting STMN alleviates the resistance to taxol and collectively contributes to down regulate the malignancy of NSCLC cells in vitro and in vivo.
    Long D; Yu T; Chen X; Liao Y; Lin X
    Cell Biol Toxicol; 2018 Feb; 34(1):7-21. PubMed ID: 28589243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro neutralization of autocrine IL‑10 affects Op18/stathmin signaling in non‑small cell lung cancer cells.
    Zhao Y; Chen S; Shen F; Long D; Yu T; Wu M; Lin X
    Oncol Rep; 2019 Jan; 41(1):501-511. PubMed ID: 30320402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction of exogenous wild‑type p53 mediates the regulation of oncoprotein 18/stathmin signaling via nuclear factor‑κB in non‑small cell lung cancer NCI‑H1299 cells.
    Chen S; Zhao Y; Shen F; Long D; Yu T; Lin X
    Oncol Rep; 2019 Mar; 41(3):2051-2059. PubMed ID: 30628717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis.
    Singer S; Ehemann V; Brauckhoff A; Keith M; Vreden S; Schirmacher P; Breuhahn K
    Hepatology; 2007 Sep; 46(3):759-68. PubMed ID: 17663418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells.
    Alli E; Yang JM; Ford JM; Hait WN
    Mol Pharmacol; 2007 May; 71(5):1233-40. PubMed ID: 17272681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane transport of WAVE2 and lamellipodia formation require Pak1 that mediates phosphorylation and recruitment of stathmin/Op18 to Pak1-WAVE2-kinesin complex.
    Takahashi K; Suzuki K
    Cell Signal; 2009 May; 21(5):695-703. PubMed ID: 19162178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
    Wang S; Akhtar J; Wang Z
    Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel.
    Feng W; Xiaoyan X; Xuan Y; Xiangke L; Zichang Y; Ran Z; Liuxing W; Qingxia F
    Cancer Gene Ther; 2015 Apr; 22(3):115-21. PubMed ID: 25572118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-encoded LMP1 triggers regulation of the ERK-mediated Op18/stathmin signaling pathway in association with cell cycle.
    Lin X; Tang M; Tao Y; Li L; Liu S; Guo L; Li Z; Ma X; Xu J; Cao Y
    Cancer Sci; 2012 Jun; 103(6):993-9. PubMed ID: 22417000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells.
    Lin X; Liu S; Luo X; Ma X; Guo L; Li L; Li Z; Tao Y; Cao Y
    Int J Cancer; 2009 Mar; 124(5):1020-7. PubMed ID: 19048596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial zinc finger 1 is involved in the regulation of angiogenesis: possible contribution of stathmin/OP18 as a downstream target gene.
    Miyashita H; Kanemura M; Yamazaki T; Abe M; Sato Y
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):878-84. PubMed ID: 15031128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stathmin/Op18 phosphorylation is regulated by microtubule assembly.
    Küntziger T; Gavet O; Manceau V; Sobel A; Bornens M
    Mol Biol Cell; 2001 Feb; 12(2):437-48. PubMed ID: 11179426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Op18/stathmin as a potential target of ASK1-p38 MAP kinase cascade.
    Mizumura K; Takeda K; Hashimoto S; Horie T; Ichijo H
    J Cell Physiol; 2006 Feb; 206(2):363-70. PubMed ID: 16110469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of anti-angiogenic effects by a combined treatment with vinblastine and rapamycin in an endothelial cell line.
    Campostrini N; Marimpietri D; Totolo A; Mancone C; Fimia GM; Ponzoni M; Righetti PG
    Proteomics; 2006 Aug; 6(15):4420-31. PubMed ID: 16888724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stathmin/Op18 is a novel mediator of vinblastine activity.
    Devred F; Tsvetkov PO; Barbier P; Allegro D; Horwitz SB; Makarov AA; Peyrot V
    FEBS Lett; 2008 Jul; 582(17):2484-8. PubMed ID: 18588888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.